WEI HU to Biomarkers, Tumor
This is a "connection" page, showing publications WEI HU has written about Biomarkers, Tumor.
Connection Strength
0.080
-
Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes. J Ovarian Res. 2014 Dec 05; 7:109.
Score: 0.031
-
Prognostic biomarkers in ovarian cancer. Cancer Biomark. 2010-2011; 8(4-5):231-51.
Score: 0.022
-
Proteomics in cancer screening and management in gynecologic cancer. Curr Oncol Rep. 2004 Nov; 6(6):456-62.
Score: 0.016
-
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904. Eur J Cancer. 2014 Jun; 50(9):1638-48.
Score: 0.008
-
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers. Clin Cancer Res. 2003 Feb; 9(2):845-52.
Score: 0.003